SBIR/STTR Research Award
Bioprinted 3D Cellularized Tissue Analogs for Regenerative Sports Medicine
Award amount
$49,768Program and phase
SBIR · Phase IAward year
2022Award details
- Awarding agency
- Department of Defense
- Branch
- Air Force
- Recipient company
- Embody, Inc.
- Proposal award date
- 2021-10-29
- Contract end date
- 2022-02-07
- UEI
- TDARNMFL46M1
- Solicitation number
- X21.2
- Topic code
- AF212-CSO1
Research abstract
Embody, Inc. has pioneered a breakthrough, scalable, and robust biomanufacturing approach producing musculoskeletal tissue-like constructs to improve the treatment, recovery rate, and regeneration of commonly injured muscles, ligaments, and tendons among
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Improving Care and Operational Readiness with 3D Bioprinted Tissue Analogs for Volumetric Muscle Loss
- Proposed Expansion of Phase II Contract #FA8649-20-9-9080
- Improving Care and Operational Readiness with Arthroscopically Delivered Collagen Microfiber-Based Biotextiles
- Improving Care and Operational Readiness with Arthroscopically Delivered Collagen Microfiber-Based Biotextiles
- Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Monitoring Evolution of Coordinated Inauthentic Behavior
- Automated Target Recognition for Rapid Multitarget Grouping, Discrimination and Neutralization
- Composite Binder Enabling Higher Propellant Loading and Performance for Extended Range and Reduced Mass Missile Propulsion
- Video Based Assessment Capabilities and Human Performance Optimization
- Secure, BYOAD Enterprise Talk, Text, Video, and Data Transmission for Air Force Special Operations Command in Communications Denied/Degraded Environments
Research funding history
9 SBIR/STTR records share this UEI (2019–2022). Reported award amounts total $7,757,313. Reported amounts are not federal obligations.
Phases: Phase II, Phase I, Phase II – Direct to Phase II
Agencies: Department of Defense, Department of Health and Human Services